TABLE 2.

Published mHealth research protocols

Authors	Study design	Population	Intervention	Primary endpoints
McGillicuddy et al45	Protocol for randomized controlled trial	Eighty kidney transplant recipients	Multilevel mobile intervention: automated reminders from electronic medication tray, tailored text messages and motivational feedback guided by self-determination theory, automated summary reports for providers	Medication adherence (>90% opening medication tray) and BP control
Jung et al46	Protocol for randomized controlled trial	One hundred fourteen kidney transplant recipients, age 8 or older, at least 1 mo posttransplant	Smart pill box equipped with a personal identification system (fingerprint); home monitoring system to save, monitor, and transmit data	Medication adherence
Pase et al47	Protocol for a randomized controlled trial	One hundred twenty-eight adolescent (13–21 y) kidney transplant recipients randomized to 2 groups	Three-month educational platform housed within a secret group on Facebook, allowing interaction between patients and the multidisciplinary team	Impact of the intervention on knowledge, self-esteem, and satisfaction
Fleming et al48	Protocol for a randomized controlled trial	One hundred thirty-six participants randomized to mHealth-based, pharmacist-led intervention vs usual posttransplant care	TRANSAFE Rx app: mobile app with real-time medication lists from transplant center EMR, medication reminders and patient-reported tracking, Bluetooth-enabled BP and BG monitors, adverse event tracking, tacrolimus CV tracking, and clinic visit adherence tracking	Incidence and severity of medication errors and adverse drug events

app, application; BG, blood glucose, BP, blood pressure; CI, confidence interval; CV, coefficient of variability; EMR, electronic medical record; mHealth, mobile health; OR, odds ratio.